Immunization with SARS Coronavirus Vaccines Leads to Pulmonary Immunopathology on Challenge with the SARS Virus | |
Anonymous Coward User ID: 78411984 United States 02/09/2020 10:59 AM Report Abusive Post Report Copyright Violation | |
Anonymous Coward User ID: 78411984 United States 02/09/2020 11:07 AM Report Abusive Post Report Copyright Violation | Re: Immunization with SARS Coronavirus Vaccines Leads to Pulmonary Immunopathology on Challenge with the SARS Virus This is the reason Americans on cruise ship infected show no signs of death or struggle..... only the Chinese vaccinated with SARS vaccine OP IS RIGHT ON MONEY SARS Vaccine combined with Corona Virus is a death sentence otherwise it’s the flu |
Anonymous Coward User ID: 78411984 United States 02/09/2020 11:14 AM Report Abusive Post Report Copyright Violation | |
Anonymous Coward User ID: 78411984 United States 02/09/2020 11:31 AM Report Abusive Post Report Copyright Violation | |
Anonymous Coward User ID: 78004549 United States 02/09/2020 11:31 AM Report Abusive Post Report Copyright Violation | Re: Immunization with SARS Coronavirus Vaccines Leads to Pulmonary Immunopathology on Challenge with the SARS Virus Immunization with SARS Coronavirus Vaccines Leads to Pulmonary Immunopathology on Challenge with the SARS Virus Quoting: Baldrick [link to journals.plos.org (secure)] These SARS-CoV vaccines all induced antibody and protection against infection with SARS-CoV. However, challenge of mice given any of the vaccines led to occurrence of Th2-type immunopathology suggesting hypersensitivity to SARS-CoV components was induced. Caution in proceeding to application of a SARS-CoV vaccine in humans is indicated. And...dodgy chinese vaccinations [link to www.theguardian.com (secure)] Report has nothing to do with SARS so it might be a big leap to think China went with a SARS vaccine becuase CCP is a caring open and transparent government as we all know... :ace2: With the highest frequency of ACE2 receptors, itll be interesting to see if they start dropping like flies. Japan is on Chinas doorstep and seem to be holding up so far. Time will tell. What is the difference with SARS-CoV and MERS-CoV - "Recent Advances in the Vaccine Development Against Middle East Respiratory Syndrome-Coronavirus" [link to www.frontiersin.org (secure)] -50% Middle East respiratory syndrome (MERS) is a deadly viral respiratory disease caused by MERS-coronavirus (MERS-CoV) infection. To date, there is no specific treatment proven effective against this viral disease. In addition, no vaccine has been licensed to prevent MERS-CoV infection thus far. Therefore, our current review focuses on the most recent studies in search of an effective MERS vaccine. Overall, vaccine candidates against MERS-CoV are mainly based upon the viral spike (S) protein, due to its vital role in the viral infectivity, although several studies focused on other viral proteins such as the nucleocapsid (N) protein, envelope (E) protein, and non-structural protein 16 (NSP16) have also been reported. In general, the potential vaccine candidates can be classified into six types: viral vector-based vaccine, DNA vaccine, subunit vaccine, nanoparticle-based vaccine, inactivated-whole virus vaccine and live-attenuated vaccine, which are discussed in detail. Besides, the immune responses and potential antibody dependent enhancement of MERS-CoV infection are extensively reviewed. In addition, animal models used to study MERS-CoV and evaluate the vaccine candidates are discussed intensively. -- So, we now have a category C bio-weapon if MERS-CoV is this classification - so is SARS-CoV |
Anonymous Coward User ID: 78004549 United States 02/09/2020 11:34 AM Report Abusive Post Report Copyright Violation | Re: Immunization with SARS Coronavirus Vaccines Leads to Pulmonary Immunopathology on Challenge with the SARS Virus Immunization with SARS Coronavirus Vaccines Leads to Pulmonary Immunopathology on Challenge with the SARS Virus Quoting: Baldrick [link to journals.plos.org (secure)] These SARS-CoV vaccines all induced antibody and protection against infection with SARS-CoV. However, challenge of mice given any of the vaccines led to occurrence of Th2-type immunopathology suggesting hypersensitivity to SARS-CoV components was induced. Caution in proceeding to application of a SARS-CoV vaccine in humans is indicated. And...dodgy chinese vaccinations [link to www.theguardian.com (secure)] Report has nothing to do with SARS so it might be a big leap to think China went with a SARS vaccine becuase CCP is a caring open and transparent government as we all know... :ace2: With the highest frequency of ACE2 receptors, itll be interesting to see if they start dropping like flies. Japan is on Chinas doorstep and seem to be holding up so far. Time will tell. What is the difference with SARS-CoV and MERS-CoV - "Recent Advances in the Vaccine Development Against Middle East Respiratory Syndrome-Coronavirus" [link to www.frontiersin.org (secure)] -50% Middle East respiratory syndrome (MERS) is a deadly viral respiratory disease caused by MERS-coronavirus (MERS-CoV) infection. To date, there is no specific treatment proven effective against this viral disease. In addition, no vaccine has been licensed to prevent MERS-CoV infection thus far. Therefore, our current review focuses on the most recent studies in search of an effective MERS vaccine. Overall, vaccine candidates against MERS-CoV are mainly based upon the viral spike (S) protein, due to its vital role in the viral infectivity, although several studies focused on other viral proteins such as the nucleocapsid (N) protein, envelope (E) protein, and non-structural protein 16 (NSP16) have also been reported. In general, the potential vaccine candidates can be classified into six types: viral vector-based vaccine, DNA vaccine, subunit vaccine, nanoparticle-based vaccine, inactivated-whole virus vaccine and live-attenuated vaccine, which are discussed in detail. Besides, the immune responses and potential antibody dependent enhancement of MERS-CoV infection are extensively reviewed. In addition, animal models used to study MERS-CoV and evaluate the vaccine candidates are discussed intensively. -- So, we now have a category C bio-weapon if MERS-CoV is this classification - so is SARS-CoV -50% Potential Antibody Dependent Enhancement (ADE) of Mers-CoV Infection Antibody dependent enhancement (ADE) is a condition whereby non-neutralizing antibodies are produced following an infection or a vaccination, which enhance the infectivity of the subsequent infection (Kuzmina et al., 2018). ADE of viral infections have been reported for dengue virus, human immunodeficiency virus, influenza virus, other alpha and flaviviruses, SARS-CoV, and Ebola virus (Dutry et al., 2011; Kuzmina et al., 2018). Thus, ADE is a critical issue that should be considered seriously in designing a MERS-CoV vaccine. Attributed to the taxonomic and structural similarities between SARS-CoV and MERS-CoV, the processes involved in development of new vaccines against these two viruses, to a large extent, are similar. Vaccine candidates against SARS-CoV were initially developed based on the full-length S protein. However, these vaccines were later demonstrated to induce non-neutralizing antibodies which did not prevent MERS-CoV infection, and the immunized animals were not protected from the viral challenge instead they experienced adverse effects like enhanced hepatitis, increased morbidity, and stronger inflammatory responses (Weingartl et al., 2004; Czub et al., 2005). Many potential vaccines against MERS-CoV were also mainly focused on the same full-length S protein, raising a safety concern on the practical application of these vaccines (Du et al., 2016b). To date, no ADE has been observed in MERS-CoV. Indeed, the ADE of SARS-CoV infection in human cells was only discovered 8 years after the virus was first identified in 2003 (Yip et al., 2011). Jaume et al. (2012) demonstrated that non-neutralizing antibodies induced by the full-length S protein of SARS-CoV facilitated the viral entry into host cells via a FcγR-dependent pathway. Our understanding about MERS-CoV is relatively lesser compared to SARS-CoV, mainly due to the fact that the former was discovered less than 7 years, thus it is unsurprising that the ADE of MERS-CoV has yet to be reported (Du et al., 2016b). Nevertheless, by employing appropriate strategies and methods, the ADE of MERS-CoV infection could be revealed in the future. Two approaches have been suggested to mitigate the adverse effects of ADE. The first approach involves shielding the non-neutralizing epitopes of the S proteins by glycosylation, whereas the second approach, namely immunofocusing, aims to direct the adaptive immune responses to target only the critical neutralizing epitope to elicit a more robust protective immunity (Du et al., 2016a; Okba et al., 2017). A supporting evidence for the latter is that a MERS-CoV vaccine candidate based on a shorter S1 domain induced slightly stronger neutralizing activity than that based on the full-length S protein. In addition, a vaccine candidate based on the even shorter RBD induced the highest neutralizing immune responses (Okba et al., 2017). |
Anonymous Coward User ID: 78004549 United States 02/09/2020 11:40 AM Report Abusive Post Report Copyright Violation | Re: Immunization with SARS Coronavirus Vaccines Leads to Pulmonary Immunopathology on Challenge with the SARS Virus Immunization with SARS Coronavirus Vaccines Leads to Pulmonary Immunopathology on Challenge with the SARS Virus Quoting: Baldrick [link to journals.plos.org (secure)] These SARS-CoV vaccines all induced antibody and protection against infection with SARS-CoV. However, challenge of mice given any of the vaccines led to occurrence of Th2-type immunopathology suggesting hypersensitivity to SARS-CoV components was induced. Caution in proceeding to application of a SARS-CoV vaccine in humans is indicated. And...dodgy chinese vaccinations [link to www.theguardian.com (secure)] Report has nothing to do with SARS so it might be a big leap to think China went with a SARS vaccine becuase CCP is a caring open and transparent government as we all know... :ace2: With the highest frequency of ACE2 receptors, itll be interesting to see if they start dropping like flies. Japan is on Chinas doorstep and seem to be holding up so far. Time will tell. What is the difference with SARS-CoV and MERS-CoV - "Recent Advances in the Vaccine Development Against Middle East Respiratory Syndrome-Coronavirus" [link to www.frontiersin.org (secure)] -50% Middle East respiratory syndrome (MERS) is a deadly viral respiratory disease caused by MERS-coronavirus (MERS-CoV) infection. To date, there is no specific treatment proven effective against this viral disease. In addition, no vaccine has been licensed to prevent MERS-CoV infection thus far. Therefore, our current review focuses on the most recent studies in search of an effective MERS vaccine. Overall, vaccine candidates against MERS-CoV are mainly based upon the viral spike (S) protein, due to its vital role in the viral infectivity, although several studies focused on other viral proteins such as the nucleocapsid (N) protein, envelope (E) protein, and non-structural protein 16 (NSP16) have also been reported. In general, the potential vaccine candidates can be classified into six types: viral vector-based vaccine, DNA vaccine, subunit vaccine, nanoparticle-based vaccine, inactivated-whole virus vaccine and live-attenuated vaccine, which are discussed in detail. Besides, the immune responses and potential antibody dependent enhancement of MERS-CoV infection are extensively reviewed. In addition, animal models used to study MERS-CoV and evaluate the vaccine candidates are discussed intensively. -- So, we now have a category C bio-weapon if MERS-CoV is this classification - so is SARS-CoV -50% Potential Antibody Dependent Enhancement (ADE) of Mers-CoV Infection Antibody dependent enhancement (ADE) is a condition whereby non-neutralizing antibodies are produced following an infection or a vaccination, which enhance the infectivity of the subsequent infection (Kuzmina et al., 2018). ADE of viral infections have been reported for dengue virus, human immunodeficiency virus, influenza virus, other alpha and flaviviruses, SARS-CoV, and Ebola virus (Dutry et al., 2011; Kuzmina et al., 2018). Thus, ADE is a critical issue that should be considered seriously in designing a MERS-CoV vaccine. Attributed to the taxonomic and structural similarities between SARS-CoV and MERS-CoV, the processes involved in development of new vaccines against these two viruses, to a large extent, are similar. Vaccine candidates against SARS-CoV were initially developed based on the full-length S protein. However, these vaccines were later demonstrated to induce non-neutralizing antibodies which did not prevent MERS-CoV infection, and the immunized animals were not protected from the viral challenge instead they experienced adverse effects like enhanced hepatitis, increased morbidity, and stronger inflammatory responses (Weingartl et al., 2004; Czub et al., 2005). Many potential vaccines against MERS-CoV were also mainly focused on the same full-length S protein, raising a safety concern on the practical application of these vaccines (Du et al., 2016b). To date, no ADE has been observed in MERS-CoV. Indeed, the ADE of SARS-CoV infection in human cells was only discovered 8 years after the virus was first identified in 2003 (Yip et al., 2011). Jaume et al. (2012) demonstrated that non-neutralizing antibodies induced by the full-length S protein of SARS-CoV facilitated the viral entry into host cells via a FcγR-dependent pathway. Our understanding about MERS-CoV is relatively lesser compared to SARS-CoV, mainly due to the fact that the former was discovered less than 7 years, thus it is unsurprising that the ADE of MERS-CoV has yet to be reported (Du et al., 2016b). Nevertheless, by employing appropriate strategies and methods, the ADE of MERS-CoV infection could be revealed in the future. Two approaches have been suggested to mitigate the adverse effects of ADE. The first approach involves shielding the non-neutralizing epitopes of the S proteins by glycosylation, whereas the second approach, namely immunofocusing, aims to direct the adaptive immune responses to target only the critical neutralizing epitope to elicit a more robust protective immunity (Du et al., 2016a; Okba et al., 2017). A supporting evidence for the latter is that a MERS-CoV vaccine candidate based on a shorter S1 domain induced slightly stronger neutralizing activity than that based on the full-length S protein. In addition, a vaccine candidate based on the even shorter RBD induced the highest neutralizing immune responses (Okba et al., 2017). Current Mers-CoV Vaccine Platforms As of now, SARS-CoV and MERS-CoV are the only coronaviruses known to cause severe diseases in human. Development of SARS vaccines was mainly focused on the S protein of SARS-CoV (Bukreyev et al., 2004; Weingartl et al., 2004; Yang et al., 2004; Czub et al., 2005; Kam et al., 2007; Lin et al., 2007; Fett et al., 2013). To date, no vaccine has been licensed to prevent MERS-CoV infection. Although several vaccine candidates are currently in clinical trials, many still remained in the pre-clinical stage. Current approaches for the development of MERS-CoV vaccines are mostly referred to the methods used for the development of SARS-CoV vaccines during the past two decades, which include: viral vector-based vaccine, DNA vaccine, subunit vaccine, virus-like particles (VLPs)-based vaccine, inactivated whole-virus (IWV) vaccine and live attenuated vaccine. |
Anonymous Coward User ID: 78411984 United States 02/09/2020 11:41 AM Report Abusive Post Report Copyright Violation | |
Anonymous Coward User ID: 78004549 United States 02/09/2020 11:43 AM Report Abusive Post Report Copyright Violation | |
Anonymous Coward User ID: 78411984 United States 02/09/2020 11:52 AM Report Abusive Post Report Copyright Violation | Re: Immunization with SARS Coronavirus Vaccines Leads to Pulmonary Immunopathology on Challenge with the SARS Virus This is the reason Americans on cruise ship infected show no signs of death or struggle..... only the Chinese vaccinated with SARS vaccine Assume everyone has or will have Corona virus in the next year Can another vaccine be created like SARS vaccine to cause a massive violent possibly terminal response by a human's immune system? Chinese that have taken SARS vaccine die now what vaccine will be introduced in the future? Who will die next time? |
Anonymous Coward User ID: 78411984 United States 02/09/2020 12:11 PM Report Abusive Post Report Copyright Violation | |
Undestroyer
Truth User ID: 77075696 United States 02/09/2020 12:56 PM Report Abusive Post Report Copyright Violation | Re: Immunization with SARS Coronavirus Vaccines Leads to Pulmonary Immunopathology on Challenge with the SARS Virus This is an important thread. Thank you op You cannot destroy my vision when you see my vision undestroyed because I am just an undestroyer. Thread: Food Combining Made Easy by Herbert Shelton a progenitor from the Natural Hygienist Movement "I am a hunter of peace, one who chases the elusive mayfly of love... errr something like that." -Vash the Stampede |
CK Dexter Haven
User ID: 77047820 Netherlands 02/09/2020 01:01 PM Report Abusive Post Report Copyright Violation | |
Anonymous Coward User ID: 78180874 United States 02/09/2020 03:03 PM Report Abusive Post Report Copyright Violation | |
Anonymous Coward User ID: 78180874 United States 02/09/2020 03:17 PM Report Abusive Post Report Copyright Violation | |
Anonymous Coward User ID: 78180874 United States 02/09/2020 03:29 PM Report Abusive Post Report Copyright Violation | |
Jungleboogie
User ID: 76648271 Canada 02/09/2020 03:58 PM Report Abusive Post Report Copyright Violation | Re: Immunization with SARS Coronavirus Vaccines Leads to Pulmonary Immunopathology on Challenge with the SARS Virus Doesnt make sense, its a diminishing return scenario, and AFAIK, there is no virus, natural or not, that can target a population that accurately. Quoting: Baldrick Wrong [link to en.wikipedia.org (secure)] Wrong Thread: HOLY SHITBALLS!!!! CHYNA TRYING TO INFILTRATE AND INFLUENCE STATE GOVERNORS!!!! WoW!!! POMPEO SPILLS THE BEANS!!! (VIDEO) Embrace the cognitive dissonance. |
Anonymous Coward User ID: 75789165 United States 02/09/2020 05:46 PM Report Abusive Post Report Copyright Violation | Re: Immunization with SARS Coronavirus Vaccines Leads to Pulmonary Immunopathology on Challenge with the SARS Virus [link to jameslyonsweiler.com (secure)] SARS Vaccine combined with Corona Virus is causing all the death in China Only country in world besides China possibly N Korea our the only countries to vaccinate for SARS LINK above has the details Cases spreading around the world but only those with SARS vaccine our dead Page 1 2 3 |
Anonymous Coward User ID: 78411984 United States 02/09/2020 08:16 PM Report Abusive Post Report Copyright Violation | |
Baldrick
(OP) User ID: 76627264 Australia 02/14/2020 11:35 PM Report Abusive Post Report Copyright Violation | Re: Immunization with SARS Coronavirus Vaccines Leads to Pulmonary Immunopathology on Challenge with the SARS Virus A SARS protein put into a coronavirus for the purpose of making the vaccine work better Quoting: Baldrick Vid Check out @cirsKaXFW9XTigv’s Tweet: [link to twitter.com (secure)] Blackadder: Baldrick, how did you manage to find a turnip that cost £400 000? Baldrick: Well, I had to haggle. |
Anonymous Coward User ID: 78349459 United States 02/15/2020 12:05 AM Report Abusive Post Report Copyright Violation | Re: Immunization with SARS Coronavirus Vaccines Leads to Pulmonary Immunopathology on Challenge with the SARS Virus A SARS protein put into a coronavirus for the purpose of making the vaccine work better Quoting: Baldrick Vid Check out @cirsKaXFW9XTigv’s Tweet: [link to twitter.com (secure)] OP Your over target The Entire Vaccine Industry in China is a Farce Has been for decades BLACK MARKET VACCINES How a New Law Turned China’s Vaccine Industry Upside-Down China is trying to inoculate itself against future faulty vaccine scandals with strict new legislation. But the changes have led to complications. [link to www.sixthtone.com] would bet my bottom dollar... for the right amount of money you could buy a CV vaccine through out China same damn thing happened in July 2019 when the Swine flu caused 1000's of pigs to be culled China is Bootleg Vaccine Central |
Baldrick
(OP) User ID: 76627264 Australia 02/15/2020 12:42 AM Report Abusive Post Report Copyright Violation | Re: Immunization with SARS Coronavirus Vaccines Leads to Pulmonary Immunopathology on Challenge with the SARS Virus A SARS protein put into a coronavirus for the purpose of making the vaccine work better Quoting: Baldrick Vid Check out @cirsKaXFW9XTigv’s Tweet: [link to twitter.com (secure)] OP Your over target The Entire Vaccine Industry in China is a Farce Has been for decades BLACK MARKET VACCINES How a New Law Turned China’s Vaccine Industry Upside-Down China is trying to inoculate itself against future faulty vaccine scandals with strict new legislation. But the changes have led to complications. [link to www.sixthtone.com] would bet my bottom dollar... for the right amount of money you could buy a CV vaccine through out China same damn thing happened in July 2019 when the Swine flu caused 1000's of pigs to be culled China is Bootleg Vaccine Central Thanks for link. May support the theory. My argument is based around there has been nothing in place to prevent any vaccine with known advesr side effects from being sold in china. None. At. All. The new laws came in to effect 1 Dec 2019. Coronebola detected prior. This may have been a dump on the pop in anticipation of profit loss via Non Gov vaccine producers. New laws were announced April 2019? Last Edited by Baldrick on 02/15/2020 12:45 AM Blackadder: Baldrick, how did you manage to find a turnip that cost £400 000? Baldrick: Well, I had to haggle. |
Baldrick
(OP) User ID: 76627264 Australia 02/15/2020 04:08 PM Report Abusive Post Report Copyright Violation | Re: Immunization with SARS Coronavirus Vaccines Leads to Pulmonary Immunopathology on Challenge with the SARS Virus CORONAVIRUS ORIGINS HYPOTHESIS TESTING Quoting: Baldrick THE HYPOTHESIS. Step 1: Background knowledge. No one could ID the novel segment. There had been 5 coronavirus outbreaks in China in seven years; 4 from the lab, 1 from a civet (cat-like animal) as an intermediate host. Vaccines made using recombined SARS spike proteins have been made and have undergone testing since the mid-2000’s. Step 2: Initial observations. I found it to match p-ShuttleSN, which was clearly related (somehow) to the Coronavirus Spike protein. Found a patent for a SARS vaccine that used pShuttle-SN to move a SARS spike protein into an adenovirus. Step 3: I made the bold conjecture, given the background knowledge of a 4:1 risk of accidental vs. laboratory release of SARS coronavirus, that this was (a) likely an accidental laboratory release, and (b) most likely of laboratory origin THE TEST: PHYLOGENETIC RELATIONSHIPS AND A SPECIAL MOTIF PATTERN. I used phylogenetics to determine the relationship of all of the Spike protein sequences I could access, including pShuttle-SN. I sought new evidence: If pShuttle-SN turned out to be most closely related to SARS CoV 2, it may well be related causally. It wasn’t. It clustered with SARS CoV-1, specifically, in what I call the “Cancer Center cluster”, with sequences from a Genome Center. While it was possible to replicate the alignment issue with other coronaviruses, it seemed to be related to a shorted N-terminal Domain of the S1 section of the Spike protein. Noted. Further test: Other artificially modified spike proteins might be most closely related to SARS CoV 2. They aren’t. A final critical test: Since SARS CoV Spike protein is different, and different because it was from nature, but, were there any reliable sequences from a natural source from long ago that had the same type of Spike protein? If so, then we have to rule out laboratory ORIGIN – as in design, because such as finding would be highly improbable. Result: Using motifs, I searched known B-Coronavirus Spike proteins to see if there were any older sequences from nature that also include the motif pattern that appears to be indicate (may be) indicative of a the special pathogenicity in SARS CoV 2. I found one that matched all of the known closest relatives and examples of SARS CoV 2. It was from 2005 and from a natural source: a bat. (Details to appear soon following peer-review or agreement to pre-publish). [link to jameslyonsweiler.com (secure)] Far less than 50% Blackadder: Baldrick, how did you manage to find a turnip that cost £400 000? Baldrick: Well, I had to haggle. |
Anonymous Coward User ID: 77794433 United States 02/15/2020 04:23 PM Report Abusive Post Report Copyright Violation | Re: Immunization with SARS Coronavirus Vaccines Leads to Pulmonary Immunopathology on Challenge with the SARS Virus OP doesn't understand what the report means. Quoting: Anonymous Coward 77222866 He also doesn't understand viruses. There is a reason we get a different flue shot every year. There is a reason vaccines only work against 1 virus. SARS and Novel Coronavirus have a totally different RNA sequence. How would you explain the two bold-font quotes from the dailymail article then (see my post above yours, about the corona quarantined cruise ship docked at a Japan harbor)? "Among the other Americans quarantined aboard the ship are Rebecca Frasure and her husband. She was shocked when a doctor on board the ship knocked on her door to inform her that her throat swab had tested positive for the virus, as she had no symptoms other than a cough. At least one person is reported in serious condition, although the person also has a pre-existing health matter. None of the others afflicted by the virus have severe symptoms, Japan's health ministry said. " |
Undestroyer
Truth User ID: 4246359 United States 02/24/2020 11:38 AM Report Abusive Post Report Copyright Violation | Re: Immunization with SARS Coronavirus Vaccines Leads to Pulmonary Immunopathology on Challenge with the SARS Virus You cannot destroy my vision when you see my vision undestroyed because I am just an undestroyer. Thread: Food Combining Made Easy by Herbert Shelton a progenitor from the Natural Hygienist Movement "I am a hunter of peace, one who chases the elusive mayfly of love... errr something like that." -Vash the Stampede |
Anonymous Coward User ID: 76495511 United States 04/16/2021 04:04 PM Report Abusive Post Report Copyright Violation | |